The purpose of this study is to establish a novel pulmonary embolism (PE) risk prediction model based on machine learning (ML) methods and to evaluate the predictive performance of the model and the contribution of variables to the predictive performance. We conducted a retrospective study at the Shanghai Tenth People's Hospital and collected the clinical data of in-patients that received pulmonary computed tomography imaging between January 1, 2014 and December 31, 2018. We trained several ML models, including logistic regression (LR), support vector machine (SVM), random forest (RF), and gradient boosting decision tree (GBDT), compared the models with representative baseline algorithms, and investigated their predictability and feature in...
International audiencePractice guidelines recommend outpatient care for selected patients with non-m...
International audienceThe determination of the clinical pretest probability using clinical predictio...
SUMMARY BACKGROUND: Pretest probability assessment is necessary to identify patients in whom pulmona...
Abstract Background Pulmonary embolisms (PE) are life‐threatening medical events, and early identifi...
Rationale: Clinical probability assessment is a fundamental step in the diagnosis of pulmonary embol...
Aims To validate a model for quantifying the prognosis of patients with pulmonary embolism (PE). The...
BACKGROUND: A simple prognostic model could help identify patients with pulmonary embolism who are a...
Aim: Pulmonary embolism (PE), is a high mortality disease which clinical suspicion and a variety of...
OBJECTIVE To validate all diagnostic prediction models for ruling out pulmonary embolism that are ea...
Statement of the problem. Pulmonary Embolism (PE) is a common, lethal and treatable condition that i...
International audienceSUMMARY BACKGROUND: Pretest probability assessment is necessary to identify pa...
RATIONALE: Patients with acute symptomatic pulmonary embolism (PE) deemed to be at low risk for earl...
Practice guidelines recommend outpatient care for selected patients with non-massive pulmonary embol...
AIMS: To validate a model for quantifying the prognosis of patients with pulmonary embolism (PE). Th...
PurposeThe aim of the study was to develop and validate machine learning models to predict the perso...
International audiencePractice guidelines recommend outpatient care for selected patients with non-m...
International audienceThe determination of the clinical pretest probability using clinical predictio...
SUMMARY BACKGROUND: Pretest probability assessment is necessary to identify patients in whom pulmona...
Abstract Background Pulmonary embolisms (PE) are life‐threatening medical events, and early identifi...
Rationale: Clinical probability assessment is a fundamental step in the diagnosis of pulmonary embol...
Aims To validate a model for quantifying the prognosis of patients with pulmonary embolism (PE). The...
BACKGROUND: A simple prognostic model could help identify patients with pulmonary embolism who are a...
Aim: Pulmonary embolism (PE), is a high mortality disease which clinical suspicion and a variety of...
OBJECTIVE To validate all diagnostic prediction models for ruling out pulmonary embolism that are ea...
Statement of the problem. Pulmonary Embolism (PE) is a common, lethal and treatable condition that i...
International audienceSUMMARY BACKGROUND: Pretest probability assessment is necessary to identify pa...
RATIONALE: Patients with acute symptomatic pulmonary embolism (PE) deemed to be at low risk for earl...
Practice guidelines recommend outpatient care for selected patients with non-massive pulmonary embol...
AIMS: To validate a model for quantifying the prognosis of patients with pulmonary embolism (PE). Th...
PurposeThe aim of the study was to develop and validate machine learning models to predict the perso...
International audiencePractice guidelines recommend outpatient care for selected patients with non-m...
International audienceThe determination of the clinical pretest probability using clinical predictio...
SUMMARY BACKGROUND: Pretest probability assessment is necessary to identify patients in whom pulmona...